28Jan 2025
Faricimab Shows Significant Improvement in DME Treatment in India

Faricimab Shows Significant Improvement in DME Treatment in India

Faricimab proves highly effective for treating diabetic macular edema (DME) in real-world clinical settings in India. Both treatment-naïve and recalcitrant eyes showed significant improvements in best-corrected visual acuity (BCVA), central macular thickness (CMT), and fluid resolution. Treatment-naïve eyes saw greater gains, with BCVA improving from 0.48 to 0.27 logMAR. No adverse events were reported, suggesting faricimab as a promising option for DME treatment. Long-term studies are recommended.

  • #ophthalmology
  • #endo-diabetology

Like

Save

Share